Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-01-18
2011-01-18
Huff, Sheela J (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
Reexamination Certificate
active
07871620
ABSTRACT:
The present invention provides for immunoliposomes that optimizes internalization of a drug into target cells bearing a characteristic cell surface marker. The immunoliposomes comprise an Fab′ domain of an antibody that specifically binds the characteristic marker, an amphipathic vesicle-forming lipid, and a polyethylene glycol derivatized lipid. The invention also provides for growth-inhibiting immunoliposomes that lack growth-inhibiting therapeutic agents and yet are capable of inhibiting the growth and proliferation of target cells.
REFERENCES:
patent: 6214388 (2001-04-01), Benz et al.
patent: 7135177 (2006-11-01), Benz et al.
patent: 7507407 (2009-03-01), Benz et al.
Park et al (PNAS vol. 92 p. 1327 (1991).
Blume et al (Biochimica Biophysica Acta 1993;1149:180-184).
Fan et al (J Biol Chem. Nov. 4, 1994;269(44):27595-602).
Sliwkowski et al (J. Biol. Chem 1994;269 (20):14661).
Benz Christopher C.
Hong Keelung
Kirpotin Dmitri
Papahadjopoulos Demetrios P.
Park John W.
Huff Sheela J
The Regents of the University of California
Townsend and Townsend / and Crew LLP
LandOfFree
Immunoliposomes that optimize internationalization into... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoliposomes that optimize internationalization into..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoliposomes that optimize internationalization into... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660523